Leen Ann M.
SEC CIK 1763026 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KLRS | Kalaris Therapeutics, Inc. | CSO | 65.3K | — | $465.5K | 3 | 2021-11-12 | 2022-08-16 |
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Leen Ann M. made no open-market trades at KLRS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2022-01-18+ | KLRS | Kalaris Therapeutics, Inc. | Leen Ann M. | CSO | A - Grant | $0.00 | +81.0K | 65.3K | New | $0 |
| 2022-08-17 | 2022-08-16 | KLRS | Kalaris Therapeutics, Inc. | Leen Ann M. | CSO | A - Grant | $0.00 | +15.0K | 43.0K | +54% | $0 | |
| MI | 2021-11-16 | 2021-11-12+ | KLRS | Kalaris Therapeutics, Inc. | Leen Ann M. | CSO | S - Sale | $22.18 | -21.0K | 2.29M | -0.9% | -$465.5K |
Purchase Sale Sale after option exercise All abbreviations